South Asian Type 2 Diabetes (SAT2D) Consortium United Kingdom (UK)
Research
Date range: 1 February 2023 - 31 January 2024
Research collaboration: South Asian Type 2 Diabetes (SAT2D) Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
South Asian Type 2 Diabetes (SAT2D) Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Aga Khan University (AKU)
- BGI
- Baker Heart and Diabetes Institute (Baker IDI)
- Baqai Institute of Diabetology & Endocrinology
- Center for Non-Communicable Diseases (CNCD)
- Diabetic Association Pakistan
- Dr Mohan's Diabetes Specialties Centre
- Duke-NUS Medical School
- Genome Institute of Singapore (GIS), A*STAR
- Imperial College Healthcare NHS Trust
- Imperial College London (ICL)
- Indian Council of Medical Research (ICMR)
- King's College London (KCL)
- London North West Healthcare NHS Trust (LNWH)
- Mauritius Ministry of Health and Wellness
- NIHR Oxford Biomedical Research Centre (OxBRC)
- National Center for Global Health and Medicine (NCGM)
- National University of Singapore (NUS)
- OU Health Sciences Center (OUHSC)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
- Oxford Wellcome Trust Centre for Human Genetics
- Queen Mary University of London (QMUL)
- Singapore Eye Research Institute (SER), SNEC
- Singapore National Eye Centre (SNEC)
- The University of Melbourne (UniMelb)
- University Hospitals Birmingham NHS Foundation Trust (UHB)
- University of Birmingham (UB)
- University of California, San Francisco (UCSF)
- University of Cambridge
- University of Colombo (UoC)
- University of Exeter
- University of Geneva (UNIGE)
- University of Kelaniya (UoK)
- University of Michigan (U-M)
- Wellcome Sanger Institute